New Markets are opening up. Technology is accelerating. It’s changing everything.
And creating fortunes in the process.Dynamic Wealth Research exposes the biggest and most profitable changes for our readers.
The Greeatest Government Giveaway In History
Seeing The Unseen
Here’s the three critical elements.
It all starts with a basic principle of microeconomics.
This principle was best summed up by Milton Friedman’s “Four Ways To Spend Money” chart.
Here is a the chart posted by the Financial Samurai to show you:
The chart explains everything about spending.
It’s simple, but it’s critical.
Every type of spending is identified.
Like when you focus on economising when spending your money on others. Think of Christmas presents.
Or like when spending someone else’s money on yourself. If you’ve ever had an expense account, you know that you tend to upgrade things you normally wouldn’t with your own money.
Well, it's spending someone else’s money on yourself that’s the type of spending that the Inflation Reduction Act.
The Inflation Reduction Act made a trade off.
It allowed Medicare to negotiate drug prices.
The actual law says the negotiations will begin initially with 10 drugs and there are many limitations from there.
That was likely the cover “win” they extracted from Big Pharma.
Of course, Big Pharma isn’t walking away empty handed.
The law also put into place a max “out of pocket” expense for prescription drugs for Medicare users at $2,000.
After that, the government covers the rest.
There will be no incentive to economize.
There will be every incentive to spend as much on the best, most potentially useful drugs even if the benefits are marginal.
We’re not debating the morals of this. There are good arguments on all sides. Just the finances.
And if you do just the numbers, the inevitable result is hundreds of billions of dollars in additional prescription drug spending between this kicking in 2025 and 2030.
And it only goes up from there because of the third part of this equation.
The third part is the U.S. population is ageing.
This decade will see the greatest surge in total Medicare patients in history.
The Big Winners